Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Melanoma 18Carcinoma, Non-Small-Cell Lung 11Squamous Cell Carcinoma of Head and Neck 7Neoplasms 7Carcinoma, Renal Cell 7Stomach Neoplasms 5Pancreatic Neoplasms 5Breast Neoplasms 5Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma, Kaposi 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lung Neoplasms 2Esthesioneuroblastoma, Olfactory 2Colonic Neoplasms 2Chondrosarcoma 2Carcinoma, Merkel Cell 2Carcinoma, Hepatocellular 2

Interventions

cemiplimab 1Therapeutics 1Radiation, Ionizing 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Mass Spectrometry 1Immunotherapy 1Imatinib Mesylate 1Drug Therapy 1Docetaxel 1Chromatography, High Pressure Liquid 1Biological Therapy 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma × Docetaxel × Dermatologic × Clear all
NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

OncoResponse, Inc.

Phase 1/2 Unknown
172 enrolled
DermatologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡